510(k) Report

PMA · Approved

Approved

Novocure Ltd's Novottf-100A Treatment Kit

P100034PMAApproved Apr 8, 2011235-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Novocure, GmbH · NZK Stimulator, Low Electric Field, Tumor Treatment

Approved on Apr 8, 2011 through premarket approval, which rests on the device’s own clinical evidence after a 235-day review.

Decided
Apr 8, 2011
Review
235 days
Class
Class III
Product code
NZK
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P100034 has 45 supplements since 2012: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2012: 22013: 42014: 42015: 32016: 32017: 12018: 32019: 22020: 12021: 42022: 12023: 12024: 72025: 42026: 5
2012high 7 (2024) · low 1 (2017)2026
View FIG. 1 as a table
YearSupplements approved
20122
20134
20144
20153
20163
20171
20183
20192
20201
20214
20221
20231
20247
20254
20265
FIG. 1 — Supplements to P100034, 2012–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NZK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All NZK devices

NZK Stimulator, Low Electric Field, Tumor Treatment: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NZK

4in 2025

2011: 12012: 22013: 42014: 42015: 32016: 32017: 12018: 32019: 22020: 12021: 42022: 12023: 12024: 72025: 42026 (partial year): 5
2007high 7 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NZK

Too few NZK 510(k)s in any year since 2007 to give a median.

Recalls per year · NZK

No recall names NZK since 2007.

Adverse event reports per year · NZK

240in 2025

2012: 122013: 222014: 112015: 232016: 92017: 122018: 232019: 212020: 302021: 322022: 262023: 292024: 1562025: 240
2007high 240 (2025) · low 0 (2007)2025

MAUDE reports naming product code NZK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20111—00
20122—012
20134—022
20144—011
20153—023
20163—09
20171—012
20183—023
20192—021
20201—030
20214—032
20221—026
20231—029
20247—0156
20254—0240
20265—0—
Cite this page

510(k) Report. “P100034: Novocure Ltd's Novottf-100A Treatment Kit.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/P100034

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026